Robert Matthew Lutz I Bio, Inc. (IBIO) insider trading activity

Robert Matthew Lutz is Officer of iBio, Inc.. Currently has a direct ownership of 102,165 shares of IBIO, which is worth approximately $272,780. The most recent transaction as insider was on Nov 11, 2022, when has been sold 100,057 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 102K

0% 3M change

0% 12M change

Total Value Held $272,780

Robert Matthew Lutz Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 11 2022	BUY Grant, award, or other acquisition	-	100,057 Added 49.48%	102,165 Common Stock
Mar 10 2022	SELL Open market or private sale	$8,619 $0.35 p/Share	24,625 Reduced 10.61%	207,375 Common Stock
Mar 04 2021	BUY Grant, award, or other acquisition	-	232,000 Added 50.0%	232,000 Common Stock

Also insider at

SBBP

Strongbridge Biopharma plc

Chief Financial Officer

SVRA

Savara Inc Healthcare

Chief Operating Officer

RML